Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.


TSXV:CVM.H - Post by User

Bullboard Posts
Comment by Looneytuneson Nov 08, 2018 5:02am
71 Views
Post# 28941989

RE:RE:RE:RE:Up a tad

RE:RE:RE:RE:Up a tadAgree with you to a large extent Growth however I do believe that the director's strategy is to sell the business to a much larger organization with larger and stronger marketing and distribution capabilities but what I'm not sure about is timescales, I'd guess that they'd need to prove the demand for the product first which might take 12 months following the start of sales. My main reason for thinking this is the split between CRVR Med and CVR Global and the fact that CVR Global seems to have retained all the IP (which they wouldn't want to lose as they'll need to re-use it to develop other products).
Bullboard Posts